← Evidence map

ReviewBlood2018

Defining success with cellular therapeutics: the current landscape for clinical end point and toxicity analysis.

Leslie S KeanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29728399